Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01009307 · ClinicalTrials.gov registry record
Study of Blood and Cheek Cell Samples From Patients With Glioma
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 1,709
- Enrollment target
NCT01009307 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 1,709 participants.
The verdict
NCT01009307 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 1,709 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at blood and cheek cell samples from patients with glioma.
Interventions
- OTHER laboratory biomarker analysis
- OTHER medical chart review
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,709 participants |
| Start Date | 2001-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01009307
The ClinicalTrials.gov registry entry for NCT01009307 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,709 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT01009307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01009307 about?
NCT01009307 is a clinical study titled "Study of Blood and Cheek Cell Samples From Patients With Glioma". RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is...
What is the current status of trial NCT01009307?
This trial is currently completed. The enrollment target is 1,709 participants. The study started on 2001-10.
What interventions are being tested in trial NCT01009307?
The interventions under investigation include: laboratory biomarker analysis (OTHER), medical chart review (OTHER), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT01009307?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.